Jaume Pons
2022
In 2022, Jaume Pons earned a total compensation of $3.7M as Chief Executive Officer and President at ALX ONCOLOGY HOLDINGS, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $272,786 |
|---|---|
| Option Awards | $2,029,250 |
| Salary | $583,500 |
| Stock Awards | $848,780 |
| Total | $3,734,316 |
Pons received $2M in option awards, accounting for 54% of the total pay in 2022.
Pons also received $272.8K in non-equity incentive plan, $583.5K in salary and $848.8K in stock awards.
Rankings
In 2022, Jaume Pons' compensation ranked 948th out of 5,756 executives tracked by ExecPay. In other words, Pons earned more than 83.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 948 out of 5,756 | 84th |
Division Manufacturing | 435 out of 3,133 | 86th |
Major group Chemicals And Allied Products | 158 out of 1,419 | 89th |
Industry group Drugs | 144 out of 1,320 | 89th |
Industry Pharmaceutical Preparations | 105 out of 966 | 89th |
Source: SEC filing on April 24, 2023.
Pons' colleagues
We found two more compensation records of executives who worked with Jaume Pons at ALX ONCOLOGY HOLDINGS in 2022.